S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
S&P 500   3,803.63
DOW   30,983.88
QQQ   316.32
Log in
NASDAQ:MRNS

Marinus Pharmaceuticals SEC Filings & 10K Form

$12.77
+0.17 (+1.35 %)
(As of 01/19/2021 01:46 PM ET)
Add
Compare
Today's Range
$12.26
Now: $12.77
$12.90
50-Day Range
$11.81
MA: $13.16
$15.89
52-Week Range
$4.16
Now: $12.77
$17.14
Volume13,202 shs
Average Volume422,060 shs
Market Capitalization$390.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.72

SEC Filings

Marinus Pharmaceuticals (NASDAQ:MRNS) SEC Filings

DateFilerForm TypeView
12/09/2020
3:40 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
3:39 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/07/2020
3:11 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/07/2020
7:03 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
3:18 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2020
9:04 AM
Marinus Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4/A
09/29/2020
3:49 PM
Domain Partners VI, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13D/A
09/22/2020
8:24 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
4:17 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
7:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
4:14 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/04/2020
7:37 PM
Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2020
7:36 PM
Austin Charles (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/27/2020
11:15 PM
Marinus Pharmaceuticals (Filer)
Form EFFECT
07/10/2020
5:02 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2020
4:20 PM
Marinus Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/17/2020
4:22 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
3:44 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
05/14/2020
11:15 PM
Marinus Pharmaceuticals (Filer)
Form EFFECT
05/11/2020
3:08 PM
Marinus Pharmaceuticals (Filer)
Form S-3/A
05/04/2020
6:57 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2020
6:45 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2020
1:27 PM
Marinus Pharmaceuticals (Filer)
Form PRE 14A
03/02/2020
8:01 AM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
02/14/2020
2:19 PM
Lion Point Capital, LP (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
02/14/2020
5:27 AM
Bain Capital Life Sciences Fund, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
9:38 AM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2020
2:05 PM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
02/03/2020
5:29 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2020
3:59 PM
Granite Point Capital Management, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
01/10/2020
3:54 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:53 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:53 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:52 PM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:52 PM
Carrazana Enrique J. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:52 PM
DOUGHERTY MICHAEL R (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
3:51 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
12:59 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
12/13/2019
4:12 PM
Boxer Capital, LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G
12/13/2019
3:16 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2019
3:08 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:06 PM
Ezickson Elan (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
4:05 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/11/2019
11:09 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
4:22 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/09/2019
6:18 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
5:56 PM
Hulihan Joseph (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2019
3:03 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:01 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2019
12:31 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
3:00 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
3:05 PM
Marinus Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
09/26/2019
11:05 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:05 PM
Lorianne Masuoka K. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2019
3:05 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:34 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:32 PM
Marinus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
3:02 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2019
3:33 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2019
3:20 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
3:02 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:59 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
4:01 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/26/2019
4:23 PM
Marinus Pharmaceuticals (Filer)
Form DEFA14A
03/25/2019
4:06 PM
Marinus Pharmaceuticals (Filer)
Form DEF 14A
03/20/2019
4:57 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
3:03 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2019
3:04 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
4:04 PM
Marinus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
11:06 AM
FRANKLIN RESOURCES INC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/28/2019
6:00 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
6:00 PM
Lorianne Masuoka K. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:59 PM
DOUGHERTY MICHAEL R (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:59 PM
Fischer Seth H. Z. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:58 PM
Marinus Pharmaceuticals (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:58 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
5:57 PM
Carrazana Enrique J. (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
4:21 PM
Marinus Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
4:11 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
10:06 AM
Bain Capital Life Sciences Fund, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/01/2019
11:02 AM
JENNISON ASSOCIATES LLC (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
02/01/2019
10:58 AM
Marinus Pharmaceuticals (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/30/2019
3:09 PM
Cashman Christopher Michael (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:08 PM
Marinus Pharmaceuticals (Issuer)
Smith Edward F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
11:26 AM
Granite Point Capital Management, L.P. (Filed by)
Marinus Pharmaceuticals (Subject)
Form SC 13G/A
12/14/2018
4:03 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2018
4:19 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/11/2018
3:40 PM
Marinus Pharmaceuticals (Filer)
Form 424B5
12/10/2018
6:35 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2018
3:05 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
3:05 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:01 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
3:04 PM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/20/2018
3:05 PM
Braunstein Scott (Reporting)
Marinus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2018
3:05 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
4:24 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
8:08 AM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2018
8:05 AM
Marinus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2018
3:15 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2018
8:17 PM
Marinus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.